The store will not work correctly when cookies are disabled.
(5-(2,3-Dichlorobenzylidene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid
ID: ALA4129136
Cas Number: 1527479-56-6
PubChem CID: 1232792
Max Phase: Preclinical
Molecular Formula: C12H7Cl2NO3S2
Molecular Weight: 348.23
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CN1C(=O)/C(=C/c2cccc(Cl)c2Cl)SC1=S
Standard InChI: InChI=1S/C12H7Cl2NO3S2/c13-7-3-1-2-6(10(7)14)4-8-11(18)15(5-9(16)17)12(19)20-8/h1-4H,5H2,(H,16,17)/b8-4-
Standard InChI Key: YYRLVKBVJKUTJD-YWEYNIOJSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
19.6208 -4.2387 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
20.4380 -4.2387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6924 -3.4620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
20.0294 -2.9799 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3707 -3.4620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.0282 -2.1627 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.9176 -4.9004 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.5934 -3.2098 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9863 -3.7569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.4699 -3.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6409 -2.4114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4185 -2.1600 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.0344 -1.8638 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
17.2099 -3.5022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6031 -4.0486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7731 -4.8488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.5553 -5.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1587 -4.5517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0410 -2.7027 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
15.8260 -3.7960 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 1 1 0
4 6 2 0
2 7 2 0
5 8 2 0
8 9 1 0
3 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
9 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 9 1 0
14 19 1 0
15 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 348.23 | Molecular Weight (Monoisotopic): 346.9244 | AlogP: 3.28 | #Rotatable Bonds: 3 |
Polar Surface Area: 57.61 | Molecular Species: ACID | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.38 | CX Basic pKa: ┄ | CX LogP: 3.65 | CX LogD: 0.24 |
Aromatic Rings: 1 | Heavy Atoms: 20 | QED Weighted: 0.67 | Np Likeness Score: -1.98 |
References
1. Zhang D, Markoulides MS, Stepanovs D, Rydzik AM, El-Hussein A, Bon C, Kamps JJAG, Umland KD, Collins PM, Cahill ST, Wang DY, von Delft F, Brem J, McDonough MA, Schofield CJ.. (2018) Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases., 26 (11): [PMID:29655609] [10.1016/j.bmc.2018.02.043] |